Sign in to view content

Phentolamine Ophthalmic Solution Rapidly Reverses Pharmacologically Induced Mydriasis in Two Pivotal Phase 3 MIRA Trials

David S. Boyer, MD

Video
Published 2022

Related

Phase 2a Study of CU06-1004, an Oral Endothelial Dysfunction Blocker for the Treatment of Diabetic Macular Edema
Victor Hugo Gonzalez, MD
Updates from the Field
2024
Performance and Usability of a Self-Operated Home Opctical Coherence Tomography (OCT) System: NOTAL-OCT V2.5 (NOV2.5)
Judy E. Kim, MD, FASRS
Updates from the Field
2019
Two-Year Results of an Ongoing Phase 1b/2 Open-Label Clinical Trial of AU-011 for the Primary Treatment of Small to Medium Choroidal Melanoma
Amy C. Schefler, MD FACS FASRS
Annual Meeting Talks
2019

Category: Pharmacology

See more